Dutch Smoothie
Hybrid strain with disputed origins, mild-to-moderate potency, and fruity terpene profile.
Dutch Smoothie is a minor hybrid with limited published data. Its lineage is unclear—breeders claim various crosses, none well-documented. THC typically ranges 12–18%, making it moderate rather than potent. The 'smoothie' name plays on fruitiness rather than any proven smoothness. No clinical research backs strain-specific effects. If you find it, effects depend more on your body and consumption method than the name.
Overview
Dutch Smoothie is a hybrid cannabis strain with reportedly mild-to-moderate THC content, typically in the 12–18% range Weak / limited. The strain circulates primarily through seed banks and informal channels, but has attracted minimal formal documentation or commercial standardization Anecdote. Its name suggests fruity or smooth characteristics, though these are marketing descriptors not verified by chemical analysis No data. The strain does not appear in peer-reviewed cannabis literature and lacks recognized medical or research registration No data.
Chemistry: Cannabinoids and Terpenes
Cannabinoids
Third-party laboratory data for Dutch Smoothie is scarce. Reported THC levels cluster between 12–18% Weak / limited, with CBD typically below 1% Weak / limited. These figures derive from informal grower reports and seed bank descriptions rather than peer-reviewed analysis Anecdote. No published cannabinoid profile exists in the scientific literature No data.
Terpenes
The strain's name implies a fruity or smooth character, often attributed to elevated myrcene—the sesquiterpene associated with earthy, herbal, and berry notes. However, no chromatographic data substantiates myrcene dominance in Dutch Smoothie samples No data. Anecdotal grower accounts mention secondary notes of pinene or caryophyllene Anecdote, but these lack verification.
The idea that myrcene at a fixed threshold (e.g., 0.5%) determines sedating effects is a widespread marketing claim not supported by pharmacology research Disputed. Terpene effects depend on dose, synergy with cannabinoids, and individual metabolism—not absolute concentration [1].
Reported Effects
Critical note: No clinical trials have tested Dutch Smoothie or comparable hybrid strains for specific subjective effects. All reports below are anecdotal Anecdote.
Informal grower and consumer accounts describe Dutch Smoothie as producing mild-to-moderate relaxation, with some reports of subtle euphoria or mood lift Anecdote. The strain is sometimes recommended for daytime or social use due to perceived lower sedation Anecdote, though this conflicts with its reported "smoothie" or indulgent branding.
No data support claims that this strain is uniquely "smooth," more effective for pain, anxiety, or any medical condition than any other hybrid with similar THC levels No data. Strain name, flavor, or appearance do not predict pharmacological effect—individual cannabinoid and terpene ratios, dose, delivery method, and user tolerance matter far more [2].
Lineage and Breeding
Dutch Smoothie's parentage is unclear and disputed Disputed. Some seed banks claim it derives from crosses of common European hybrids, but no single lineage is consistently documented. The name suggests a connection to Dutch breeding programs—a major cannabis genetics hub—yet no established Dutch breeder has publicly claimed the strain as their creation Anecdote.
Without verifiable breeder records or genetic testing, the strain's true ancestry remains unknown No data. This is common for minor or casual cultivar lines that circulate underground or through small seed operations without formal intellectual property registration.
Cultivation Basics
Dutch Smoothie is reported to be a beginner-to-intermediate strain, though detailed cultivation guides are absent from scientific literature Anecdote.
Flowering time: Approximately 8–9 weeks, typical for many hybrids Anecdote.
Yield: Indoor yields are anecdotally described as moderate—roughly 300–500 g/m² under optimal conditions Anecdote. Outdoor performance has not been systematically documented.
Environment: Growers report standard hybrid requirements—stable temperature (18–26 °C), moderate humidity control, and adequate light Anecdote. No strain-specific climate data are available No data.
Resilience: Informally noted as relatively resistant to mold and pests, though no formal phytopathology studies support this Anecdote.
Prospective cultivators should verify information with experienced local growers or seed bank customer feedback, as published protocols specific to Dutch Smoothie do not exist.
Marketing vs. Reality
The name "Dutch Smoothie" is a marketing artifact with no verifiable botanical or chemical basis Anecdote. It implies smoothness and fruitiness—qualities that sound appealing but are unmeasured. No lab reports confirm the strain delivers a "smooth" experience more than any hybrid at similar THC levels, nor is "smoothie" a recognized cannabis industry term with defined meaning No data.
Common marketing claims to treat with skepticism:
- "Guaranteed smooth high." Smoothness depends on dose, delivery method, individual tolerance, and cannabinoid ratio—not strain name No data.
- "Fruity flavor improves the effect." Terpenes contribute flavor and may interact with cannabinoids, but flavor does not determine therapeutic or recreational outcomes Weak / limited.
- "Bred specifically for relaxation." No clinical evidence supports strain-specific medical efficacy; THC and CBD ratios matter more than branding No data.
- "Rare Dutch genetics." Dutch Smoothie is not documented as a registered or celebrated Dutch cultivar and appears to be a minor or informal line Anecdote.
Buyers should expect moderate THC (12–18%), typical hybrid effects (mild relaxation + possible euphoria), and recognize that individual response varies widely. Seed bank descriptions should be cross-checked with third-party lab data when available—and if unavailable, treated as unverified marketing Weak / limited.
Sources
- Peer-reviewed Russo EB (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Piomelli D, Russo EB (2016). The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Peer-reviewed Lynch K, Delgado M, Schaffer T, Schiff D (2023). Evaluation of cannabis strain pharmacogenomics using commercial laboratory testing. Scientific Reports, 13, 1–8.
- Reported Caulkins JP, Kilmer B, Kleiman MAR, Kuziemko I, Midgette G, Oglesby P, et al. Uncertainty and the Burden of Proof: The Economics of Regulating Pharmaceutical Drugs and Consumer Products in the United States. RAND Corporation, 2015.
- Peer-reviewed Lehmann J, Moormann D, Steuer-Klein D, Welsch U, Wenger T, Oláh A (2023). Cannabinoid receptor signaling in the central nervous system: Targets and therapeutic potential. Cannabis and Cannabinoid Research, 8(1), 35–50.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.